ImmuneCyte Inc. is a global, clinical-stage biopharmaceutical company engaged in the research and development of innovative cell and gene therapeutics, including the fourth generation chimeric antigen receptor (CAR)-T cell, CAR-NK cell, and mononuclear cell therapies, for the treatment of cancer and vascular diseases. With global coronavirus pandemic, ImmuneCyte is also developing a multitiered immunotherapies in the fight against Covid-19.
Connect with us at www.immunecyte.com, on Facebook at www.facebook.com/ImmuneCyte and on Instagram @ImmuneCyte.
Company Details
- Address
- 185 Technology Drive, Suite 150, Irvine,california 92618,united States
- Industry
- Biotechnology
- Website
- immunecyte.com
- HQ
- Irvine, California
Immunecyte, Inc. Questions
Immunecyte, Inc.'s website is immunecyte.com
Immunecyte, Inc.'s LinkedIn profile is https://www.linkedin.com/company/immunecytelifesciences
Immunecyte, Inc.'s industry is
Biotechnology
Immunecyte, Inc.'s top competitors are
Gatc Health,
Genetex, Inc.,
Invitrx Therapeutics,
Biotimes Inc.,
Immunis, Inc.,
Arvetas Biosciences,
Aivita Biomedical, Inc.,
Aracari Biosciences Inc.,
Translucence Biosystems,
Advanbio.
Immunecyte, Inc.'s categories are Biotechnology
